A complete application in a minute
Tailored resume and cover letter, ready to send.
Apellis Pharmaceuticals is seeking a Director, Business Intelligence (BI) – EMPAVELI to drive market insights for US EMPAVELI in PNH. This role partners with US commercial teams and cross-functional stakeholders to translate sales analytics and market research into actionable strategies.
Strong background in biotech analytics and rare diseases is required. The position reports to the Senior Director, BI & Commercial Operations and requires leadership across teams, budget ownership, and strategic
Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.
We are seeking a talented and energetic Director, Business Intelligence (BI) – EMPAVELI who will play a key role in the commercialization of EMPAVELI in PNH. The Director will be accountable for partnering closely with U.S. commercial, and cross-functional teams to generate market-specific insights from sales and performance analytics and primary market research, to create integrated, actionable insights for cross-functional stakeholder groups across the organization. The ideal candidate must have significant experience working in a commercial insights and analytics position within a biotech or biopharma company, focusing on rare diseases (hematology a plus). The Director will report to the Senior Director, Business Intelligence & Commercial Operations – EMPAVELI, and is expected to drive market knowledge and insights that foster cross-functional action, shaping strategy and tactical execution for EMPAVELI in PNH in the US.
B.S. degree required (business, biology, or medicine-related degree preferred); advanced Degree (MBA, PhD, PharmD) preferred
10+ years in an insights and analytics function within a biotech or biopharma organization
Must-Haves:
Seasoned in commercial assessments, asset evaluation, and prioritization
Hybrid
Domestic retravel may be required in this role (up to 20%)
Bachelor’s Degree
Apellis offers a comprehensive benefits package, inclusive flexible time off, summer and winter shutdowns, paid family leave and more!
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life‑changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3‑targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first‑ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
For more information, please visit http://apellis.com or follow us on LinkedIn and X.
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.